Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

INCR - Intercure Ltd.


IEX Last Trade
1.72
0.030   1.744%

Share volume: 145
Last Updated: Wed 15 Jan 2025 06:45:19 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.09%

PREVIOUS CLOSE
CHG
CHG%

$1.69
0.09
5.52%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
0.90%
1 Month
18.18%
3 Months
-6.90%
6 Months
-29.29%
1 Year
14.97%
2 Year
-54.20%
Key data
Stock price
$1.72
P/E Ratio 
0.00
DAY RANGE
$1.72 - $1.72
EPS 
$0.00
52 WEEK RANGE
$1.24 - $3.71
52 WEEK CHANGE
$19.86
MARKET CAP 
102.454 M
YIELD 
N/A
SHARES OUTSTANDING 
45.134 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.28
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$18,361
AVERAGE 30 VOLUME 
$52,661
Company detail
CEO: Alexander Rabinovitch
Region: US
Website: intercure.co
Employees: 350
IPO year: 2019
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

InterCure Ltd. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector.

Recent news